{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,10]],"date-time":"2026-03-10T12:44:14Z","timestamp":1773146654430,"version":"3.50.1"},"reference-count":42,"publisher":"Elsevier BV","issue":"45","license":[{"start":{"date-parts":[[2011,10,1]],"date-time":"2011-10-01T00:00:00Z","timestamp":1317427200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"name":"Department of Biotechnology, Government of India"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2011,10]]},"DOI":"10.1016\/j.vaccine.2011.08.029","type":"journal-article","created":{"date-parts":[[2011,8,21]],"date-time":"2011-08-21T17:48:50Z","timestamp":1313948930000},"page":"8118-8125","source":"Crossref","is-referenced-by-count":22,"title":["Over-expression of superoxide dismutase obliterates the protective effect of BCG against tuberculosis by modulating innate and adaptive immune responses"],"prefix":"10.1016","volume":"29","author":[{"given":"Ruchi","family":"Jain","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bappaditya","family":"Dey","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Aparna","family":"Khera","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Priyadarshani","family":"Srivastav","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Umesh D.","family":"Gupta","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"V.M.","family":"Katoch","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"V.D.","family":"Ramanathan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anil K.","family":"Tyagi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"Feb (1)","key":"10.1016\/j.vaccine.2011.08.029_bib0005","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1016\/S0952-7915(99)00052-7","article-title":"Reactive oxygen and reactive nitrogen intermediates in innate and specific immunity","volume":"12","author":"Bogdan","year":"2000","journal-title":"Curr Opin Immunol"},{"issue":"Aug 1 (16)","key":"10.1016\/j.vaccine.2011.08.029_bib0010","doi-asserted-by":"crossref","first-page":"8841","DOI":"10.1073\/pnas.97.16.8841","article-title":"Reactive oxygen and nitrogen intermediates in the relationship between mammalian hosts and microbial pathogens","volume":"97","author":"Nathan","year":"2000","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"Feb 12 (7)","key":"10.1016\/j.vaccine.2011.08.029_bib0015","doi-asserted-by":"crossref","first-page":"4281","DOI":"10.1074\/jbc.274.7.4281","article-title":"Export of recombinant Mycobacterium tuberculosis superoxide dismutase is dependent upon both information in the protein and mycobacterial export machinery. A model for studying export of leaderless proteins by pathogenic mycobacteria","volume":"274","author":"Harth","year":"1999","journal-title":"J Biol Chem"},{"issue":"Aug (8)","key":"10.1016\/j.vaccine.2011.08.029_bib0020","doi-asserted-by":"crossref","first-page":"4980","DOI":"10.1128\/IAI.69.8.4980-4987.2001","article-title":"Cu,Zn superoxide dismutase of Mycobacterium tuberculosis contributes to survival in activated macrophages that are generating an oxidative burst","volume":"69","author":"Piddington","year":"2001","journal-title":"Infect Immun"},{"issue":"Dec 15 (12)","key":"10.1016\/j.vaccine.2011.08.029_bib0025","doi-asserted-by":"crossref","first-page":"2213","DOI":"10.1164\/ajrccm.164.12.2106093","article-title":"Iron-cofactored superoxide dismutase inhibits host responses to Mycobacterium tuberculosis","volume":"164","author":"Edwards","year":"2001","journal-title":"Am J Respir Crit Care Med"},{"issue":"Jan (1)","key":"10.1016\/j.vaccine.2011.08.029_bib0030","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1128\/IAI.69.1.529-533.2001","article-title":"Role of Mycobacterium tuberculosis copper-zinc superoxide dismutase","volume":"69","author":"Dussurget","year":"2001","journal-title":"Infect Immun"},{"issue":"Feb (2)","key":"10.1016\/j.vaccine.2011.08.029_bib0035","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1128\/IAI.00974-07","article-title":"Global transcriptional profile of Mycobacterium tuberculosis during THP-1 human macrophage infection","volume":"76","author":"Fontan","year":"2008","journal-title":"Infect Immun"},{"issue":"Apr (4)","key":"10.1016\/j.vaccine.2011.08.029_bib0040","doi-asserted-by":"crossref","first-page":"2412","DOI":"10.1128\/IAI.72.4.2412-2415.2004","article-title":"HLA-A2-restricted CD8+-cytotoxic-T-cell responses to novel epitopes in Mycobacterium tuberculosis superoxide dismutase, alanine dehydrogenase, and glutamine synthetase","volume":"72","author":"Dong","year":"2004","journal-title":"Infect Immun"},{"issue":"Jun (Pt 6)","key":"10.1016\/j.vaccine.2011.08.029_bib0045","doi-asserted-by":"crossref","first-page":"1375","DOI":"10.1099\/13500872-142-6-1375","article-title":"A major T-cell-inducing cytosolic 23kDa protein antigen of the vaccine candidate Mycobacterium habana is superoxide dismutase","volume":"142","author":"Bisht","year":"1996","journal-title":"Microbiology"},{"issue":"Dec (6)","key":"10.1016\/j.vaccine.2011.08.029_bib0050","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1016\/0962-8479(93)90082-9","article-title":"Superoxide dismutase activity of Mycobacterium tuberculosis isolated from tuberculosis patients and the immunoreactivity of superoxide dismutase from M. tuberculosis H37Rv","volume":"74","author":"Deshpande","year":"1993","journal-title":"Tuber Lung Dis"},{"issue":"Mar 2 (9)","key":"10.1016\/j.vaccine.2011.08.029_bib0055","doi-asserted-by":"crossref","first-page":"698","DOI":"10.1001\/jama.1994.03510330076038","article-title":"Efficacy of BCG vaccine in the prevention of tuberculosis. Meta-analysis of the published literature","volume":"271","author":"Colditz","year":"1994","journal-title":"JAMA"},{"issue":"Dec 1 (48\u201349)","key":"10.1016\/j.vaccine.2011.08.029_bib0060","doi-asserted-by":"crossref","first-page":"5655","DOI":"10.1016\/j.vaccine.2005.03.056","article-title":"Elicitation of efficient, protective immune responses by using DNA vaccines against tuberculosis","volume":"23","author":"Khera","year":"2005","journal-title":"Vaccine"},{"issue":"Apr 29 (1)","key":"10.1016\/j.vaccine.2011.08.029_bib0065","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/S0378-1119(96)00746-9","article-title":"Construction of shuttle vectors for genetic manipulation and molecular analysis of mycobacteria","volume":"190","author":"Jain","year":"1997","journal-title":"Gene"},{"issue":"Sep 15 (2)","key":"10.1016\/j.vaccine.2011.08.029_bib0070","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1111\/j.1574-6968.2000.tb09304.x","article-title":"approach for development of vaccines: cloning and expression of immunodominant antigens of M. tuberculosis","volume":"190","author":"Dhar","year":"2000","journal-title":"FEMS Microbiol Lett"},{"issue":"12","key":"10.1016\/j.vaccine.2011.08.029_bib0075","doi-asserted-by":"crossref","first-page":"e3869","DOI":"10.1371\/journal.pone.0003869","article-title":"Enhanced and enduring protection against tuberculosis by recombinant BCG-Ag85C and its association with modulation of cytokine profile in lung","volume":"3","author":"Jain","year":"2008","journal-title":"PLoS One"},{"issue":"Jan\u2013Mar (1\u20132)","key":"10.1016\/j.vaccine.2011.08.029_bib0080","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/j.tube.2004.09.009","article-title":"Evaluation of vaccines in the EU TB Vaccine Cluster using a guinea pig aerosol infection model of tuberculosis","volume":"85","author":"Williams","year":"2005","journal-title":"Tuberculosis (Edinb)"},{"issue":"Feb (1)","key":"10.1016\/j.vaccine.2011.08.029_bib0085","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1007\/s00430-002-0170-x","article-title":"Immunogenicity of recombinant BCG vaccine strains overexpressing components of the antigen 85 complex of Mycobacterium tuberculosis","volume":"193","author":"Dhar","year":"2004","journal-title":"Med Microbiol Immunol"},{"key":"10.1016\/j.vaccine.2011.08.029_bib0090","series-title":"Encyclopedia of Life Sciences","article-title":"Immunoregulation","author":"O'Shea JJaN","year":"2001"},{"key":"10.1016\/j.vaccine.2011.08.029_bib0095","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1146\/annurev.immunol.19.1.93","article-title":"Immunology of tuberculosis","volume":"19","author":"Flynn","year":"2001","journal-title":"Annu Rev Immunol"},{"issue":"Apr (4)","key":"10.1016\/j.vaccine.2011.08.029_bib0100","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1038\/nri2274","article-title":"T-cell quality in memory and protection: implications for vaccine design","volume":"8","author":"Seder","year":"2008","journal-title":"Nat Rev Immunol"},{"issue":"1\u20132","key":"10.1016\/j.vaccine.2011.08.029_bib0105","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/j.tube.2003.08.010","article-title":"Immunology of tuberculosis and implications in vaccine development","volume":"84","author":"Flynn","year":"2004","journal-title":"Tuberculosis (Edinb)"},{"issue":"Jan\u2013Mar (1\u20132)","key":"10.1016\/j.vaccine.2011.08.029_bib0110","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/j.tube.2004.08.001","article-title":"Mouse and guinea pig models for testing new tuberculosis vaccines","volume":"85","author":"Orme","year":"2005","journal-title":"Tuberculosis (Edinb)"},{"issue":"Jan 9 (1)","key":"10.1016\/j.vaccine.2011.08.029_bib0115","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1016\/j.vaccine.2005.07.078","article-title":"Preclinical testing of new vaccines for tuberculosis: a comprehensive review","volume":"24","author":"Orme","year":"2006","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2011.08.029_bib0120","series-title":"Mouse model of tuberculosis","year":"1994"},{"key":"10.1016\/j.vaccine.2011.08.029_bib0125","series-title":"Guinea model of tuberculosis","year":"1994"},{"issue":"Mar (3)","key":"10.1016\/j.vaccine.2011.08.029_bib0130","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/S1471-4914(00)01901-8","article-title":"Disease model: pulmonary tuberculosis","volume":"7","author":"McMurray","year":"2001","journal-title":"Trends Mol Med"},{"issue":"May (5\u20136)","key":"10.1016\/j.vaccine.2011.08.029_bib0135","doi-asserted-by":"crossref","first-page":"905","DOI":"10.1016\/j.micinf.2005.03.008","article-title":"The use of animal models to guide rational vaccine design","volume":"7","author":"Orme","year":"2005","journal-title":"Microbes Infect"},{"issue":"Aug (16)","key":"10.1016\/j.vaccine.2011.08.029_bib0140","doi-asserted-by":"crossref","first-page":"8468","DOI":"10.1128\/JVI.00228-07","article-title":"Multiple-cytokine-producing antiviral CD4 T cells are functionally superior to single-cytokine-producing cells","volume":"81","author":"Kannanganat","year":"2007","journal-title":"J Virol"},{"issue":"Jun 15 (12)","key":"10.1016\/j.vaccine.2011.08.029_bib0145","doi-asserted-by":"crossref","first-page":"4781","DOI":"10.1182\/blood-2005-12-4818","article-title":"HIV nonprogressors preferentially maintain highly functional HIV-specific CD8+ T cells","volume":"107","author":"Betts","year":"2006","journal-title":"Blood"},{"issue":"Jul (7)","key":"10.1016\/j.vaccine.2011.08.029_bib0150","doi-asserted-by":"crossref","first-page":"843","DOI":"10.1038\/nm1592","article-title":"Multifunctional TH1 cells define a correlate of vaccine-mediated protection against Leishmania major","volume":"13","author":"Darrah","year":"2007","journal-title":"Nat Med"},{"issue":"Nov (11)","key":"10.1016\/j.vaccine.2011.08.029_bib0155","doi-asserted-by":"crossref","first-page":"3089","DOI":"10.1002\/eji.200737504","article-title":"Immunisation with BCG and recombinant MVA85A induces long-lasting, polyfunctional Mycobacterium tuberculosis-specific CD4+ memory T lymphocyte populations","volume":"37","author":"Beveridge","year":"2007","journal-title":"Eur J Immunol"},{"issue":"Feb (2)","key":"10.1016\/j.vaccine.2011.08.029_bib0160","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1038\/nm.2285","article-title":"A multistage tuberculosis vaccine that confers efficient protection before and after exposure","volume":"17","author":"Aagaard","year":"2011","journal-title":"Nat Med"},{"issue":"Nov (21)","key":"10.1016\/j.vaccine.2011.08.029_bib0165","doi-asserted-by":"crossref","first-page":"12071","DOI":"10.1128\/JVI.01261-07","article-title":"Human immunodeficiency virus type 1 controllers but not noncontrollers maintain CD4 T cells coexpressing three cytokines","volume":"81","author":"Kannanganat","year":"2007","journal-title":"J Virol"},{"issue":"Apr (4)","key":"10.1016\/j.vaccine.2011.08.029_bib0170","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/S0167-5699(00)01612-1","article-title":"The prime-boost strategy: exciting prospects for improved vaccination","volume":"21","author":"Ramshaw","year":"2000","journal-title":"Immunol Today"},{"issue":"Jul 15 (2)","key":"10.1016\/j.vaccine.2011.08.029_bib0175","doi-asserted-by":"crossref","first-page":"831","DOI":"10.4049\/jimmunol.177.2.831","article-title":"Stimulation history dictates memory CD8 T cell phenotype: implications for prime-boost vaccination","volume":"177","author":"Masopust","year":"2006","journal-title":"J Immunol"},{"issue":"Aug (8)","key":"10.1016\/j.vaccine.2011.08.029_bib0180","doi-asserted-by":"crossref","first-page":"2279","DOI":"10.1172\/JCI31947","article-title":"Enhanced priming of adaptive immunity by a proapoptotic mutant of Mycobacterium tuberculosis","volume":"117","author":"Hinchey","year":"2007","journal-title":"J Clin Invest"},{"issue":"5","key":"10.1016\/j.vaccine.2011.08.029_bib0185","doi-asserted-by":"crossref","first-page":"e5531","DOI":"10.1371\/journal.pone.0005531","article-title":"Reducing the activity and secretion of microbial antioxidants enhances the immunogenicity of BCG","volume":"4","author":"Sadagopal","year":"2009","journal-title":"PLoS One"},{"issue":"Aug (8)","key":"10.1016\/j.vaccine.2011.08.029_bib0190","doi-asserted-by":"crossref","first-page":"1039","DOI":"10.1038\/nm906","article-title":"Apoptosis facilitates antigen presentation to T lymphocytes through MHC-I and CD1 in tuberculosis","volume":"9","author":"Schaible","year":"2003","journal-title":"Nat Med"},{"issue":"Aug (4)","key":"10.1016\/j.vaccine.2011.08.029_bib0195","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1111\/j.1440-1711.2005.01323.x","article-title":"Reactive oxygen species are essential mediators in antigen presentation by Kupffer cells","volume":"83","author":"Maemura","year":"2005","journal-title":"Immunol Cell Biol"},{"issue":"Mar 27 (13)","key":"10.1016\/j.vaccine.2011.08.029_bib0200","doi-asserted-by":"crossref","first-page":"5596","DOI":"10.1073\/pnas.0700869104","article-title":"Genome plasticity of BCG and impact on vaccine efficacy","volume":"104","author":"Brosch","year":"2007","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"Jun 30 (2)","key":"10.1016\/j.vaccine.2011.08.029_bib0205","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1002\/1097-0061(20000630)17:2<111::AID-YEA17>3.0.CO;2-G","article-title":"Comparative genomics uncovers large tandem chromosomal duplications in Mycobacterium bovis BCG Pasteur","volume":"17","author":"Brosch","year":"2000","journal-title":"Yeast"},{"issue":"Jan (1)","key":"10.1016\/j.vaccine.2011.08.029_bib0210","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1111\/j.1742-4658.2008.06755.x","article-title":"Studies on structural and functional divergence among seven WhiB proteins of Mycobacterium tuberculosis H37Rv","volume":"276","author":"Alam","year":"2009","journal-title":"FEBS J"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X11012606?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X11012606?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,11,30]],"date-time":"2018-11-30T16:25:47Z","timestamp":1543595147000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X11012606"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,10]]},"references-count":42,"journal-issue":{"issue":"45","published-print":{"date-parts":[[2011,10]]}},"alternative-id":["S0264410X11012606"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2011.08.029","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2011,10]]}}}